Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Anal Chem ; 86(19): 9443-50, 2014 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-24641163

RESUMEN

This study proposes a vascular endothelial growth factor (VEGF) biosensor for diagnosing various stages of cervical carcinoma. In addition, VEGF concentrations at various stages of cancer therapy are determined and compared to data obtained by computed tomography (CT) and cancer antigen 125 (CA-125). The increase in VEGF concentrations during operations offers useful insight into dosage timing during cancer therapy. This biosensor uses Avastin as the biorecognition element for the potential cancer biomarker VEGF and is based on a n-type polycrystalline silicon nanowire field-effect transistor (poly-SiNW-FET). Magnetic nanoparticles with poly[aniline-co-N-(1-one-butyric acid) aniline]-Fe3O4 (SPAnH-Fe3O4) shell-core structures are used as carriers for Avastin loading and provide rapid purification due to their magnetic properties, which prevent the loss of bioactivity; furthermore, the high surface area of these structures increases the quantity of Avastin immobilized. Average concentrations in human blood for species that interfere with detection specificity are also evaluated. The detection range of the biosensor for serum samples covers the results expected from both healthy individuals and cancer patients.


Asunto(s)
Anticuerpos Monoclonales Humanizados/química , Técnicas Biosensibles , Antígeno Ca-125/sangre , Carcinoma/diagnóstico , Proteínas de la Membrana/sangre , Neoplasias del Cuello Uterino/diagnóstico , Factor A de Crecimiento Endotelial Vascular/sangre , Anticuerpos Monoclonales Humanizados/inmunología , Bevacizumab , Antígeno Ca-125/análisis , Carcinoma/sangre , Carcinoma/inmunología , Carcinoma/patología , Femenino , Óxido Ferrosoférrico/química , Humanos , Imanes , Proteínas de la Membrana/análisis , Nanocables/química , Estadificación de Neoplasias , Silicio/química , Tomografía Computarizada por Rayos X , Transistores Electrónicos , Neoplasias del Cuello Uterino/sangre , Neoplasias del Cuello Uterino/inmunología , Neoplasias del Cuello Uterino/patología
2.
Sensors (Basel) ; 12(4): 3952-63, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22666012

RESUMEN

This paper reports a versatile nano-sensor technology using "top-down" poly-silicon nanowire field-effect transistors (FETs) in the conventional Complementary Metal-Oxide Semiconductor (CMOS)-compatible semiconductor process. The nanowire manufacturing technique reduced nanowire width scaling to 50 nm without use of extra lithography equipment, and exhibited superior device uniformity. These n type polysilicon nanowire FETs have positive pH sensitivity (100 mV/pH) and sensitive deoxyribonucleic acid (DNA) detection ability (100 pM) at normal system operation voltages. Specially designed oxide-nitride-oxide buried oxide nanowire realizes an electrically V(th)-adjustable sensor to compensate device variation. These nanowire FETs also enable non-volatile memory application for a large and steady V(th) adjustment window (>2 V Programming/Erasing window). The CMOS-compatible manufacturing technique of polysilicon nanowire FETs offers a possible solution for commercial System-on-Chip biosensor application, which enables portable physiology monitoring and in situ recording.


Asunto(s)
Nanocables , Semiconductores , Silicio/química , ADN/análisis , Concentración de Iones de Hidrógeno , Microscopía Electrónica de Rastreo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA